Home β€Ί Stock analysis β€Ί SIBN

Si-Bone (SIBN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

SIBN dips 1.2% to $19.68 on 2.2x normal volume. Closed at $19.68, -1.16% vs the prior close of $19.91. Day range $19.19–$19.99, opened at $19.91.

Last close$19.68-1.16%
Day range19.19–19.99
Open19.91
Volume1.17M
52-week range11.48–21.89
Avg volume (20d)599.60K

SIBN daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” SIBN dips 1.2% to $19.68 on 2.2x normal volume
Oct 15, 2026 β€” SIBN rises 2.3% to $19.91
Oct 14, 2026 β€” SIBN dips 1.1% to $19.47
Oct 13, 2026 β€” SIBN dips 2.1% to $19.68
Oct 12, 2026 β€” SIBN jumps 3.8% to $20.10, a 6-month high
Oct 9, 2026 β€” SIBN rises 2.7% to $19.37
Oct 8, 2026 β€” SIBN dips 1.3% to $18.86, 3 down days in a row
Oct 7, 2026 β€” SIBN dips 2.3% to $19.10
Oct 6, 2026 β€” SIBN dips 1.3% to $19.55
Oct 5, 2026 β€” SIBN jumps 9.6% to $19.81, a 1-month high
Oct 2, 2026 β€” SIBN dips 1.8% to $18.08, 3 down days in a row

SIBN latest news & SEC filings

Every SEC filing by or about SIBN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 14, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001218802-26-000006

Oct 13, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001950047-26-010155

Oct 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001754765-26-000007

Oct 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001853089-26-000009

Oct 5, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001035986-26-000007

Oct 5, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001950047-26-010051

Sep 11, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001459839-26-000076

Aug 14, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001011438-26-000539

Aug 4, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001459839-26-000069

Aug 3, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001459839-26-000066

Jul 30, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0002012383-26-003149

Things to know before you trade SIBN

SIBN market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202619.9119.9919.1919.681.17M
Oct 15, 202619.5120.0519.5119.91467.20K
Oct 14, 202619.6219.8719.4219.47407.80K
Oct 13, 202620.1920.2619.6619.68442.60K
Oct 12, 202619.4020.1119.3620.10553.60K
Oct 9, 202618.9019.4418.9019.37555.90K
Oct 8, 202618.9819.1218.4218.86762.80K
Oct 7, 202619.2719.6918.9819.10547.60K
Oct 6, 202619.9220.0019.2119.55538.70K
Oct 5, 202618.2619.8418.2619.81632.00K
Oct 2, 202618.6018.8017.9518.08547.30K
Oct 1, 202618.8719.0418.2718.41653.00K
Sep 30, 202619.1519.2718.8018.80640.20K
Sep 29, 202618.9219.6018.6119.15624.10K
Sep 28, 202618.5918.8218.4018.76461.60K
Sep 25, 202618.4418.7618.2918.59625.80K
Sep 24, 202618.6018.7718.2918.52630.20K
Sep 23, 202618.7618.8118.1518.60514.70K
Sep 22, 202618.6318.8718.5918.81450.10K
Sep 21, 202618.1918.5517.8218.45771.10K

About Si-Bone

Si-Bone (SIBN) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in SANTA CLARA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1459839.

SIBN board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Jeffrey W DunnDirectorSep 3, 2026
Timothy E Jr DavisDirectorJun 8, 2026
Laura FrancisChief Executive OfficerAug 26, 2026
John Gordon FreundDirectorJun 8, 2026
Jeryl L HillemanDirectorJun 9, 2026
Greg K HinckleyDirectorApr 9, 2026
Mika NishimuraDirectorJun 8, 2026
Thomas A. WestDirectorJun 8, 2026

Executive officers

NameTitleLatest filing
Laura FrancisChief Executive OfficerAug 26, 2026
Anshul MaheshwariChief Op & Financial OfficerAug 26, 2026
Michael A. PisetskySVP, Ops & Adm/Chief Legal OfrAug 18, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 1, 2026Jeffrey W DunnSale1,367$18.91
Sep 1, 2026Jeffrey W DunnSale18,633$18.91
Sep 1, 2026Jeffrey W DunnSale1,367$18.91
Sep 1, 2026Jeffrey W DunnSale18,633$18.91
Sep 1, 2026Jeffrey W DunnSale1,367$18.91
Sep 1, 2026Jeffrey W DunnSale18,633$18.91
Sep 1, 2026Jeffrey W DunnSale1,367$18.91
Sep 1, 2026Jeffrey W DunnSale18,633$18.91
Aug 24, 2026Anshul MaheshwariSale11,636$20.11
Aug 24, 2026Anshul MaheshwariSale11,636$20.11
Aug 24, 2026Anshul MaheshwariSale11,636$20.11
Aug 24, 2026Anshul MaheshwariSale11,636$20.11
Aug 24, 2026Laura FrancisSale25,972$20.12
Aug 24, 2026Laura FrancisSale25,972$20.12
Aug 24, 2026Laura FrancisSale25,972$20.12

SIBN financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$200.93M$-18.90M-0.44$-675.00K
Dec 31, 2024$167.18M$-30.91M-0.75$-12.43M
Dec 31, 2023$138.89M$-43.34M-1.13$-18.71M
Dec 31, 2022$106.41M$-61.26M-1.79$-41.66M
Dec 31, 2021$90.15M$-56.57M-1.71$-39.53M

Latest balance sheet: total assets $248.76M, total liabilities $66.41M, cash $33.13M (as of Jun 30, 2026).

SIBN earnings / results-day log

DateFilingClose that day
Aug 3, 20268-K Item 2.02 (results)$18.45
May 11, 20268-K Item 2.02 (results)$11.61
Feb 23, 20268-K Item 2.02 (results)$15.62
Jan 12, 20268-K Item 2.02 (results)$17.87
Nov 10, 20258-K Item 2.02 (results)$15.68
Aug 4, 20258-K Item 2.02 (results)$17.90
May 5, 20258-K Item 2.02 (results)$14.25
Feb 24, 20258-K Item 2.02 (results)$17.47
Jan 13, 20258-K Item 2.02 (results)$16.23
Nov 12, 20248-K Item 2.02 (results)$15.63
Aug 5, 20248-K Item 2.02 (results)β€”
May 6, 20248-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on SIBN

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.